FMP

FMP

Enter

VINC - Vincerx Pharma, Inc.

Financial Summary of Vincerx Pharma, Inc.(VINC), Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies

photo-url-https://financialmodelingprep.com/image-stock/VINC.png

Vincerx Pharma, Inc.

VINC

NASDAQ

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

0.93 USD

-0.02 (-2.15%)

About

ceo

Dr. Ahmed M. Hamdy M.D.

sector

Healthcare

industry

Biotechnology

website

https://vincerx.com

exchange

NASDAQ

Description

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

CIK

0001796129

ISIN

US92731L1061

CUSIP

92731L106

Address

260 Sheridan Avenue

Phone

650 800 6676

Country

US

Employee

42

IPO Date

May 27, 2020

Summary

CIK

0001796129

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

92731L106

ISIN

US92731L1061

Country

US

Price

0.93

Beta

0.81

Volume Avg.

1.15M

Market Cap

19.91M

Shares

-

52-Week

0.61-9.372

DCF

0.49

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.49

P/B

-

Website

https://vincerx.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest VINC News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep